Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Cintinuous infusion cisplatin, 5-FU and high-dose leucovorin (PFL): An induction therapy for squamous cell carcinoma of the head and neck (SCCHN) with high rates of complete respoonse and radiotherapy alone as primary site management

Cintinuous infusion cisplatin, 5-FU and high-dose leucovorin (PFL): An induction therapy for squamous cell carcinoma of the head and neck (SCCHN) with high rates of complete respoonse and radiotherapy alone as primary site management. Presented 6th International Conference on the Adjuvant Therapy of Cancer, Tuscon, AZ. 1990.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.